JP2018515612A5 - - Google Patents

Download PDF

Info

Publication number
JP2018515612A5
JP2018515612A5 JP2018511333A JP2018511333A JP2018515612A5 JP 2018515612 A5 JP2018515612 A5 JP 2018515612A5 JP 2018511333 A JP2018511333 A JP 2018511333A JP 2018511333 A JP2018511333 A JP 2018511333A JP 2018515612 A5 JP2018515612 A5 JP 2018515612A5
Authority
JP
Japan
Prior art keywords
methyl
quinoxalin
indol
amine
pyridin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2018511333A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018515612A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2016/000783 external-priority patent/WO2016180536A1/en
Publication of JP2018515612A publication Critical patent/JP2018515612A/ja
Publication of JP2018515612A5 publication Critical patent/JP2018515612A5/ja
Pending legal-status Critical Current

Links

JP2018511333A 2015-05-13 2016-05-12 置換キノキサリン誘導体 Pending JP2018515612A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP15001451.2 2015-05-13
EP15460017.5 2015-05-13
EP15001451 2015-05-13
EP15460017 2015-05-14
PCT/EP2016/000783 WO2016180536A1 (en) 2015-05-13 2016-05-12 Substituted quinoxaline derivatives

Publications (2)

Publication Number Publication Date
JP2018515612A JP2018515612A (ja) 2018-06-14
JP2018515612A5 true JP2018515612A5 (enExample) 2019-06-13

Family

ID=56081443

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018511333A Pending JP2018515612A (ja) 2015-05-13 2016-05-12 置換キノキサリン誘導体

Country Status (9)

Country Link
US (1) US20180148429A1 (enExample)
EP (1) EP3294729A1 (enExample)
JP (1) JP2018515612A (enExample)
CN (1) CN107635986A (enExample)
AU (1) AU2016261031A1 (enExample)
CA (1) CA2979302A1 (enExample)
IL (1) IL254870A0 (enExample)
TW (1) TW201713641A (enExample)
WO (1) WO2016180536A1 (enExample)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2823180T3 (es) * 2016-07-14 2021-05-06 Bristol Myers Squibb Co Compuestos bicíclicos sustituidos con heteroarilo
EP3538518A1 (en) * 2016-11-08 2019-09-18 Merck Patent GmbH Substituted quinoxaline derivatives as inhibitors of pfkfb
GB201705263D0 (en) * 2017-03-31 2017-05-17 Probiodrug Ag Novel inhibitors
US20200275661A1 (en) * 2017-09-26 2020-09-03 Nippon Soda Co., Ltd. Quinoline compound, and agricultural and horticultural fungicide
EP3737680A1 (en) 2018-01-08 2020-11-18 F. Hoffmann-La Roche AG Octahydropyrido[1,2-alpha]pyrazines as magl inhibitors
DK3768684T3 (da) 2018-03-22 2023-04-24 Hoffmann La Roche Oxazin-monoacylglycerol-lipase (MAGL)-hæmmere
JP7478142B2 (ja) 2018-06-07 2024-05-02 ディスアーム セラピューティクス, インコーポレイテッド Sarm1阻害剤
MY210507A (en) 2018-08-13 2025-09-28 Hoffmann La Roche New heterocyclic compounds as monoacylglycerol lipase inhibitors
JP2022508751A (ja) * 2018-10-15 2022-01-19 ゲロ ディスカバリー リミテッド ライアビリティ カンパニー Pfkfb3阻害剤とその使用
WO2020104494A1 (en) 2018-11-22 2020-05-28 F. Hoffmann-La Roche Ag New heterocyclic compounds
AU2019387370A1 (en) 2018-11-30 2021-06-10 Nuvation Bio Inc. Pyrrole and pyrazole compounds and methods of use thereof
CA3123215C (en) 2018-12-19 2024-04-02 Disarm Therapeutics, Inc. Inhibitors of sarm1 in combination with neuroprotective agents
CN114072405A (zh) 2019-07-03 2022-02-18 豪夫迈·罗氏有限公司 杂环单酰基甘油脂肪酶(magl)抑制剂
KR20220034104A (ko) 2019-07-09 2022-03-17 에프. 호프만-라 로슈 아게 신규 헤테로고리 화합물
CN121045142A (zh) * 2019-08-06 2025-12-02 北卡罗来纳查佩尔山大学 Rna靶向配体、其组合物以及其制备和使用方法
CN110698418B (zh) * 2019-09-11 2022-07-01 广西师范大学 一种3-芳胺基喹喔啉-2-甲酰胺类衍生物及其制备方法和应用
PH12022550339A1 (en) 2019-09-12 2023-03-13 Hoffmann La Roche 4,4a,5,7,8,8a-hexapyrido[4,3-b][1,4]oxazin-3-one compounds as magl inhibitors
MX2022003023A (es) 2019-09-23 2022-04-07 Hoffmann La Roche Compuestos heterociclicos.
CN115515959B (zh) * 2020-05-08 2026-03-31 默克专利股份公司 用作tead结合剂的三环杂环
EP4185564A1 (en) * 2020-07-23 2023-05-31 Merck Patent GmbH Tricyclic heterocycles
WO2022043284A1 (en) 2020-08-26 2022-03-03 F. Hoffmann-La Roche Ag Heterocyclic compounds useful as magl inhibitors
PE20231372A1 (es) 2020-09-03 2023-09-07 Hoffmann La Roche Compuestos heterociclicos
WO2022115521A1 (en) 2020-11-25 2022-06-02 Servier Pharmaceuticals, Llc (heteo)aryl substituted pyrrolo-, pyrazolo- and triazolopyridazine derivates as mat2a inhibitors
EP4337653A4 (en) * 2021-06-02 2025-07-23 Univ North Carolina Chapel Hill RNA TARGETING LIGANDS, COMPOSITIONS THEREOF, AND METHODS OF MAKING AND USING THE SAME
WO2023247670A1 (en) 2022-06-24 2023-12-28 F. Hoffmann-La Roche Ag New heterocyclic-carbonyl-cyclic compounds as magl inhibitors
WO2025084787A1 (ko) * 2023-10-17 2025-04-24 가천대학교 산학협력단 신규 퀴녹살린 화합물, 이의 제조방법 및 이의 용도

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5633218A (en) * 1995-05-24 1997-05-27 E. I. Du Pont De Nemours And Company Herbicidal benzodioxoles and benzodioxanes
US20140128392A1 (en) * 2009-03-19 2014-05-08 Bioenergenix Heterocyclic compounds for the inhibition of pask
US9403769B2 (en) * 2010-02-22 2016-08-02 Advanced Cancer Therapeutics, Llc Small molecule inhibitors of PFKFB3 and glycolytic flux and their methods of use as anti-cancer therapeutics
TW201311149A (zh) * 2011-06-24 2013-03-16 Ishihara Sangyo Kaisha 有害生物防治劑
WO2013148228A1 (en) * 2012-03-29 2013-10-03 Advanced Cancer Therapeutics, Llc Pfkfb3 inhibitor and methods of use as an anti-cancer therapeutic

Similar Documents

Publication Publication Date Title
JP7058636B2 (ja) サイクリン依存性キナーゼ7(cdk7)の阻害剤
US11130759B1 (en) 2-oxoquinazoline derivatives as methionine adenosyltransferase 2A inhibitors
JP7086395B2 (ja) 置換インドールMcl-1阻害剤
JP7076741B2 (ja) Bmpシグナル阻害化合物
JP6117235B2 (ja) Pi3kの活性または機能の阻害剤の使用
ES2966457T3 (es) Derivados de pirazol como inhibidores de MALT1
TW201713641A (zh) 經取代之喹喏啉衍生物
JP2013501002A (ja) Sykキナーゼ阻害剤としての化合物および組成物
JP2015503504A (ja) ヘテロアリールおよびその使用
KR20160135283A (ko) 5-치환된 인다졸-3-카르복스아미드 및 이의 제조 및 용도
CN107922431A (zh) Hpk1抑制剂及其使用方法
JP2013500972A (ja) Sykキナーゼ阻害剤としての2,7−ナフチリジン−1−オン誘導体
MX2010008421A (es) Compuestos y composiciones como inhbidores de cinasa.
KR20130038420A (ko) 브루톤 티로신 키나아제의 억제제
CA2798622A1 (en) Indoles
AU2012318874A1 (en) 1,3-substituted azetidine PDE10 inhibitors
JP2016508490A (ja) 置換2−アミノピリジンプロテインキナーゼ阻害剤
JP2010538094A (ja) チロシンキナーゼ阻害剤としてのピラゾロピリジン類
JP2023526841A (ja) ピペラジン環状尿素類
TW202509019A (zh) Sarm1調節子、其製劑及用途
JP2024511841A (ja) 置換された1-アリール-1’-ヘテロアリール化合物、置換された1,1’-ビヘテロアリール化合物、及びこれらを使用する方法
JP2025512957A (ja) Egfr阻害剤
CN121586713A (zh) 用于治疗疾病的喹啉衍生物及其药物组合物
AU2024284667A1 (en) Pyrazolo-pyrimidinone compounds for use in methods of inhibiting wee1 a kinase
CA3245810A1 (en) PYRIDO[3,2-D]PYRIMIDINS USED AS HPK1 INHIBITORS